Cargando…

Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention

BACKGROUND: Previous studies have suggested a strong association of liver fibrosis scores (LFSs) with cardiovascular outcomes in patients with different cardiovascular diseases. Nonetheless, it is basically blank regarding the prognostic significance of LFSs in patients following percutaneous corona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui‐Hui, Cao, Ye‐Xuan, Jin, Jing‐Lu, Hua, Qi, Li, Yan‐Fang, Guo, Yuan‐Lin, Zhu, Cheng‐Gang, Wu, Na‐Qiong, Gao, Run‐Lin, Li, Jian‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955446/ https://www.ncbi.nlm.nih.gov/pubmed/33506689 http://dx.doi.org/10.1161/JAHA.120.018869

Ejemplares similares

Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus
por: Li, Xiao-Lin, et al.
Publicado: (2014)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long‐Term Follow‐up Study on Real‐World Patients Receiving Percutaneous Coronary Intervention
por: Liu, Hui‐Hui, et al.
Publicado: (2020)

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study
por: Liu, Hui-Hui, et al.
Publicado: (2019)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Elective percutaneous liver biopsy and use of aspirin
por: Reynard, Maxence Emmanuel, et al.
Publicado: (2022)

Predictive Value of Systemic Inflammation Score for Contrast-Associated Acute Kidney Injury and Adverse Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention
por: Zeng, Ji-Lang, et al.
Publicado: (2023)

Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)

Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Mehta, Vimal, et al.
Publicado: (2016)

A Systematic Review on Bleeding Risk Scores’ Accuracy after Percutaneous Coronary Interventions in Acute and Elective Settings
por: Brinza, Crischentian, et al.
Publicado: (2021)

Prediction of Length of Stay Following Elective Percutaneous Coronary Intervention
por: Negassa, Abdissa, et al.
Publicado: (2011)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Fracture guide wire during an elective percutaneous coronary intervention
por: Samanidis, George, et al.
Publicado: (2017)

Association of prealbumin levels with contrast-induced acute kidney injury in elderly patients with elective percutaneous coronary intervention
por: You, Zhe-Bin, et al.
Publicado: (2018)

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2021)

The Effect of Elective Percutaneous Coronary Intervention of the Right Coronary Artery on Right Ventricular Function
por: Nikdoust, Farahnaz, et al.
Publicado: (2014)

Same‐Day Discharge After Elective Uncomplicated Percutaneous Coronary Interventions
por: Patel, Kunal, et al.
Publicado: (2019)

Validation of algorithms to identify elective percutaneous coronary interventions in administrative databases
por: Derington, Catherine G., et al.
Publicado: (2020)

Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study
por: Almeida, Adriana Silveira, et al.
Publicado: (2020)

Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population
por: Xiong, Shengjun, et al.
Publicado: (2023)

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Pang, Zhihua, et al.
Publicado: (2017)

Relationship between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2015)

Changes in Heart Rate Variability Parameters after Elective Percutaneous Coronary Intervention
por: Abrootan, Saeed, et al.
Publicado: (2015)

Same‐Day Discharge After Elective Percutaneous Coronary Interventions in Ontario, Canada
por: Madan, Mina, et al.
Publicado: (2019)

Left Ventricular Twist and Untwist in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Elzieny, Ali A., et al.
Publicado: (2021)

Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
por: Nogami, Kai, et al.
Publicado: (2022)

Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease
por: Liu, Shuo-Lin, et al.
Publicado: (2020)

The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Choi, Woong gil, et al.
Publicado: (2018)

Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease
por: Zhang, Hui-Wen, et al.
Publicado: (2017)

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2020)

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Jian, Wen, et al.
Publicado: (2020)

Self-management of coronary heart disease in older patients after elective percutaneous transluminal coronary angioplasty
por: Dawkes, Susan, et al.
Publicado: (2016)

Mean Corpuscular Volume Predicts In-Stent Restenosis Risk for Stable Coronary Artery Disease Patients Receiving Elective Percutaneous Coronary Intervention
por: Sun, Lin, et al.
Publicado: (2019)

Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention
por: Peng, Yang-Pei, et al.
Publicado: (2020)

Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention
por: Takahashi, Shuhei, et al.
Publicado: (2016)

Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study
por: Zhang, Hui-Wen, et al.
Publicado: (2020)

ADS Score as a Novel Predictor of Outcomes in Patients Who Underwent Percutaneous Coronary Intervention
por: Zhang, Wen-Jing, et al.
Publicado: (2021)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Harada, Yukinori, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_igc9imljet15593t1jcnv9v34n